Trius Therapeutics Inc's ROI from its second quarter of 2013 to the second quarter of 2012 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Trius Therapeutics Inc's ROI in the second quarter of 2013?
Trius Therapeutics Inc recorded a cumulative net loss of $-69 million during 12 months ending in the second quarter of 2013, resulting in a negative return on investment (ROI) of -112.41%.

Within the Healthcare sector 87 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2013 from 0 to 1263.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Jun 30 2013) II. Quarter	(Mar 31 2013) I. Quarter	(Dec 31 2012) IV. Quarter	(Sep 30 2012) III. Quarter	(Jun 30 2012) II. Quarter
Y / Y Investment Change TTM	-12.78 %	7.84 %	41.61 %	83.17 %	205.45 %
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	55	72	57	61	78
Return On Investment (TTM)	-112.41 %	-94.72 %	-74.94 %	-56.52 %	-10.97 %
TSRX's Overall Ranking	# 1263	# 0	# 0	# 0	# 0
Seq. Investment Change TTM	-8.76 %	-6.68 %	2.45 %	-0.01 %	12.81 %
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-69	-64	-54	-40	-8

TSRX Company Profile >> Back to TSRX Roi Comparisons >> See Annual TSRX Return On Investment

Return On Investment TSRX's Ranking
Within:	No.
Industry	# 19
Sector	# 88
Overall	# 1263

Return On Investment Statistics
High	Average	Low
-74.94 %	-94.02 %	-112.41 %
(Dec 31 2012)		(Jun 30 2013)

Financial Statements
Trius Therapeutics Inc's II. Quarter Investments	$ 55 Millions	TSRX's Balance sheet
Trius Therapeutics Inc's II. Quarter Income	$ -20 Millions	Quarterly TSRX's Income Statement
TSRX's Income by Division		See TSRX's Income by Division

TSRX Annual Return On Investment	(Dec 31 2012) 2012	(Dec 31 2011) 2011
Total Investments in Millions	57	50	0	0	0
Y / Y Investment Growth	13.82 %	-	-	-	-
Net Income in Millions	-54	-18	0	0	0
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-94.97 %	-36.58 %	-	-	-

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
TSRX's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for TSRX's Competitors
Subscribers only: Roi for Trius Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for TSRX's Customers

Other Ratios
TSRX's Roa	TSRX's Inventory Turnover Ratio	TSRX's Growth Rates	TSRX's Dividend Statistics
	TSRX's Profitability Ratios	TSRX's Asset Turnover Ratio	TSRX's Dividend Growth
TSRX's Roe	TSRX's Valuation Ratios	TSRX's Financial Strength Ratios	TSRX's Dividend Payout Ratio

Companies with similar Return On Investment at Jun 30 2013, within Healthcare Sector

ROI

Date modified: 2026-09-18T13:11:02+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.